A--Drug Manufacturing and Formulation Program (DMFP)
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The National Institutes of Health (NIH), under the Department of Health and Human Services, has awarded four (4) Indefinite Delivery/Indefinite Quantity (IDIQ) contracts for the Drug Manufacturing and Formulation Program (DMFP). These awards have a maximum ordering value of $49,999,999.00 and an ordering period spanning from May 4, 2026, through May 3, 2036. Concurrently, initial task orders totaling $5,000.00 were issued to each awardee.
Scope of Work
The awarded contracts are for services related to Drug Manufacturing and Formulation, falling under the product and service code AN11 (Health R&D Services; Health Care Services; Basic Research). The specific details of the manufacturing and formulation activities are not provided in this award notice but are implied by the program title.
Contract & Timeline
- Contract Type: Indefinite Delivery/Indefinite Quantity (IDIQ)
- Number of Awards: Four (4)
- Maximum Ordering Value: $49,999,999.00
- Ordering Period: May 4, 2026 – May 3, 2036
- Award Date: May 4, 2026
- Initial Task Orders: $5,000.00 (firm-fixed price, effective May 4, 2026 – July 3, 2026)
- Set-Aside: Not specified
- Place of Performance: Menlo Park, CA
Agency & Contacts
- Department: Health And Human Services
- Sub-Tier: NATIONAL INSTITUTES OF HEALTH
- Office: NATIONAL INSTITUTES OF HEALTH NIDA
- Primary Contact: PLUGGE, RIEKA N (rieka.plugge@nih.gov)
- Secondary Contact: Kelly Dempsey (kelly.dempsey@nih.gov)